Screener
Dyne Therapeutics, Inc. DYN Operating Lease Liabilities
Operating Lease Liabilities at other companies
Other financials
Where this comes from
Reported directly by Dyne Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseLiabilityNoncurrent.
The source filing: Dyne Therapeutics, Inc.’s 10-Q, filed May 11, 2026.
- Filed
- May 11, 2026, 7:25 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-215702
| Line item | March 31, 2026 | December 31, 2025 |
|---|---|---|
| Lease liabilities | 5,033 | 4,995 |
| Total current liabilities | 51,249 | 50,625 |
| Long-term debt, net | 149,375 | 148,921 |
| Lease liabilities, net of current portion | 14,271 | 15,283 |
| Total liabilities | 214,895 | 214,829 |
| Stockholders’ equity | ||
| Preferred stock, $0.0001 par value; 10,000,000 shares authorized at March 31, 2026 and December 31, 2025 | — | — |
| Common stock, $0.0001 par value; 200,000,000 shares authorized at March 31, 2026 and December 31, 2025; 165,201,329 and 164,950,540 shares issued and outstanding at March 31, 2026 and December 31, 2025, respectively | 16 | 16 |
Item 1. Condensed Consolidated Financial Statements (Unaudited)
FAQ
- What is Dyne Therapeutics, Inc.'s operating lease liabilities?
- Dyne Therapeutics, Inc. (DYN) reported operating lease liabilities of $14.27M in Q1 2026.
- How has Dyne Therapeutics, Inc.'s operating lease liabilities changed year-over-year?
- Dyne Therapeutics, Inc.'s operating lease liabilities decreased by 21.7% year-over-year, from $18.22M to $14.27M.
- What does operating lease liabilities mean?
- Long-term portion of operating lease obligations extending beyond one year, representing committed future rent payments.
Ask your AI about Dyne Therapeutics, Inc.'s operating lease liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude